TR
Trevena, Inc.
TRVN · OTC
$0.01 +0.00% (+$0.00)
1M +1,020.00%
Market Cap $9.67K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.00x
PEG N/A
P/B N/A
Growth
23 /100
Declining Rev. growth 0.60%
FCF growth N/A
Book val. growth N/A
Profitability
19 /100
Weak Net margin 1,289.25%
Op. margin 1,129.22%
FCF margin 1,058.43%
Quality
1 /100
Poor ROA 99.22%
Asset turnover 0.08x
ROIC 104.42%
Debt
100 /100
Low Current ratio 4.66x
Int. coverage N/A
Net debt/EBITDA N/A
Stability
25 /100
Unstable Rev. volatility 564.93%
EPS volatility 48.03%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na TRVN
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Carrie L. Bourdow
Employees
23
Headquarters
Chesterbrook
Nadcházející události
05 LIS
Earnings
Upcoming earnings report